Multiplexed Metagenomic Deep Sequencing To Analyze the Composition of High-Priority Pathogen Reagents
Year: 2016
Type: article
Abstract: Both the integrity and reproducibility of experiments using select agents depend in large part on unbiased validation to ensure the correct identity and purity of the species in question. Metagenomic deep sequencing (MDS) provides the required level of validation by allowing for an unbiased and comprehensive assessment of all the microbes in a laboratory stock.
Source: mSystems
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $3,500
Funders: Howard Hughes Medical Institute, National Institutes of Health, Genentech, University of California, San Francisco, National Institute of General Medical Sciences, National Institute of Allergy and Infectious Diseases, National Institute of Biomedical Imaging and Bioengineering, National Center for Advancing Translational Sciences
Awards: Development of Near Real-Time, Multiplexed Diagnostics for Viral Hemorrhagic Feve, G1217462604, Role for polyamines in Ebola Virus Replication, G3519246167, BMI Bioinformatics Training Grant, G5718272591, G585910909, National Center/Emerging Infectous Diseases &Biodefense, Integrative Program in Complex Biological System (ipCBS), Early Host Immune Response in Protection Against Filovirus Infection, G9000044274, G9000152088, National Emerging Infectious Diseases Laboratories Operations
OpenAlex ID: W2501797992